Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Five New York City Democrats are competing to become the left-leaning candidate of choice in the June mayoral primary.

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

During remission, new symptoms typically resolve or improve. MS is a chronic, progressive condition of the central nervous system (CNS) in which your immune system attacks myelin, the protective ...

However, benign MS may change to a progressive form of MS. Multiple sclerosis (MS) can vary greatly from person to person. Benign MS is a term sometimes used to describe a form of MS in which a ...

“We are excited to announce this breakthrough in understanding how nasal foralumab induces immune modulation in Secondary Progressive MS patients,” said Dr. Tanuja Chitnis, M.D., Principal ...

Ocrelizumab and hyaluronidase is now the first and only twice-yearly subcutaneous injection approved for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).

Background Treatment options for patients suffering from progressive forms of multiple sclerosis (MS) remain inadequate. Mast cells actively participate in the pathogenesis of MS, in part because ...

Phone addictions are a real problem – and working from home might be making them worse according to The Observer columnist ...

Roche is running three late-stage studies, namely FENhance 1 and 2 trials in relapsing MS, comparing the drug to Sanofi's Aubagio (teriflunomide) and the FENtrepid trial in primary progressive MS ...